NYSE - Nasdaq Real Time Price
USD
Nuvation Bio Inc. (NUVB)
4.1600
-0.0300
(-0.72%)
At close: November 6 at 4:00:02 PM EST
4.1900
+0.0300
(+0.72%)
After hours: November 6 at 6:45:56 PM EST
Trade NUVB on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutNuvation Bio reported $45.0 million in third-quarter 2026 revenue, led by 18% sequential growth in IBTROZI U.S. net product revenue. Safusidenib produced encouraging Phase 2 durability data, while the company expanded its Phase 3 SIGMA trial and plans additional data presentations in November. Cash and marketable securities totaled $663.4 million, but operating expenses remained higher than revenue.
